Patents Assigned to Genitrix LLC
  • Patent number: 7371387
    Abstract: The invention provides compositions and methods for modulating immune responses in subjects. The invention is based, at least in part, on the discovery that an in-frame translation fusion of an antigen with an APC binding domain of an opsonin forms a molecule, that is, a fusion polypeptide, which when administered to a subject modulates an immune response to the antigen.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: May 13, 2008
    Assignee: Genitrix LLC
    Inventor: Andrew Segal
  • Patent number: 6632436
    Abstract: The invention provides compositions and methods for modulating immune responses in subjects. The invention is based, at least in part, on the discovery that an in-frame translation fusion of an antigen with an APC binding domain of an opsonin forms a molecule, that is, a fusion polypeptide, which when administered to a subject modulates an immune response to the antigen.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: October 14, 2003
    Assignee: Genitrix LLC
    Inventor: Andrew Segal